Retail & Wholesale » Retail | Pharmarise Holdings Corp.

Pharmarise Holdings Corp. | Income Statement

Fiscal year is June-May. All values JPY Millions.
2014
2015
2016
2017
2018
Sales/Revenue
38,221
39,506
48,512
52,949
54,562
Cost of Goods Sold (COGS) incl. D&A
32,803
33,745
42,193
46,387
47,312
Gross Income
5,418
5,762
6,319
6,562
7,250
SG&A Expense
1,328
2,394
2,930
3,594
3,547
EBIT
2,597
1,161
818
483
1,181
Unusual Expense
83
54
382
254
676
Non Operating Income/Expense
106
45
55
11
50
Interest Expense
203
177
161
127
106
Pretax Income
1,156
943
1,025
1
414
Income Tax
779
715
655
251
622
Consolidated Net Income
377
229
369
249
208
Net Income
369
228
382
8
29
Net Income After Extraordinaries
369
228
382
8
29
Net Income Available to Common
369
228
382
7
28
EPS (Basic)
46.55
25.31
42.44
0.78
3.10
Basic Shares Outstanding
8
9
9
9
9
EPS (Diluted)
46.31
24.99
41.55
0.75
3.10
Diluted Shares Outstanding
8
9
9
9
9
EBITDA
3,679
2,319
2,017
1,776
2,507
Other Operating Expense
1,493
2,206
2,571
2,485
2,522
Non-Operating Interest Income
7
5
7
5
6
Minority Interest Expense
8
1
13
257
179
Equity in Affiliates (Pretax)
31
37
76
94
39

About Pharmarise Holdings

View Profile
Address
Sumitomo Nakano Sakaue Building, 8/F
Tokyo Tokyo 164
Japan
Employees -
Website http://www.pharmarise.com
Updated 07/08/2019
Pharmarise Holdings Corp. engages in the management of its group pharmacies. Its operations are carried out through the Dispensing Pharmacy Business and Others segments. The Dispensing Pharmacy Business segment deals with dispensing medicine to patients under the health insurance system.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.